Clinical trial Recruiting at 5 sites Observational Ages 18 and up

Evaluating heart health in patients with high blood pressure

Official title: Subendocardial Viability Ratio in Hypertension

Run by Istituto Auxologico Italiano · NCT06309511 · Data updated 2026-11-12

This study tests a new way to check heart health in people with high blood pressure to see if it can help predict heart-related problems.

More Hypertension trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment3000 (estimated)
SponsorIstituto Auxologico Italiano
Academic / other
Locations5 sites (Mascalucia, Catania and 4 other locations)
StatusRecruiting
StartedOctober 1, 2022
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedAugust 3, 2025
Trial IDNCT06309511 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals diagnosed with hypertension.

Probably not a fit

Patients with atrial fibrillation will not benefit from this study due to exclusion criteria.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research aims to assess the Subendocardial Viability Ratio (SEVR) in patients with hypertension using non-invasive arterial tonometry. The study will measure the SEVR by analyzing the central pressure wave morphology and correlating it with various anthropometric and pathology variables. By understanding the SEVR, the study seeks to identify factors that may predict cardiovascular morbidity and mortality in individuals with high blood pressure. Participants will be recruited from specialized Arterial Hypertension Centers.

Why it matters

Potential benefit: If successful, this study could help predict cardiovascular risks in hypertensive patients, leading to better management and treatment strategies.

How similar studies have gone: Other studies have explored similar methodologies in assessing cardiovascular health in hypertensive patients, indicating potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Hypertension

Exclusion Criteria:

* Atrial fibrillation

Where it's running

  • Centro di Prevenzione e Cura dell'Ipertensione Arteriosa "Alessandro Filippi"
    Mascalucia, Catania, Italy
    Recruiting
  • Unità Operativa Semplice Dipartimentale Ipertensione Arteriosa "Anna Maria Pirrelli", Università degli Studi di Bari "Aldo Moro". Policlinico Consorziale di Bari
    Bari, Italy
    Recruiting
  • Istituto Auxologico Italiano IRCCS
    Milan, Italy
    Recruiting
  • Medicina II Cardiovascolare, AUSL-IRCCS di Reggio Emilia
    Reggio Emilia, Italy
    Recruiting
  • Dipartimento di Scienze Mediche, Chirurgiche e della Salute, Università degli studi di Trieste
    Trieste, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.